Jackie Grant

Jackie Grant is an investment professional at Abingworth, a transatlantic life sciences venture capital firm based in Boston. She has over 12 years of life science experience, including translational research, business development, and investing. Jackie represents Abingworth on the boards of Atsena Therapeutics and Nido Biosciences and is an observer on the Anjarium and Glycomine boards.

Previously, Jackie was a Senior Associate at SV Health Investors. She was formerly in the Business Development Group at Genentech with primary responsibility for partnering activities in neuroscience. Her transactions span a broad spectrum of deal structures and therapeutic areas, including technology and platform in-licenses and research collaborations. Jackie has a Ph.D. in Neuroscience from the Stanford School of Medicine and an MBA from the Stanford Graduate School of Business.